IL-6/GP130 SIGNALING AS A NOVEL CHEMOPREVENTION TARGET FOR TRIPLE-NEGATIVE BREAST CANCER

$1,096,764FY2020Defense Health AgencyDOD

University Of Maryland, Baltimore

Investigators

IL-6/GP130 SIGNALING AS A NOVEL CHEMOPREVENTION TARGET FOR TRIPLE-NEGATIVE BREAST CANCER · GrantIndex